IGFBP3 and prostate cancer: Finally, Seligson et al. (18) observed increased IGFBP-3 staining in both the cytoplasm and nucleus of prostate cancers compared to benign tissue, but only the nuclear staining was significantly prognostic for cancer recurrence, being more highly predictive than baseline PSA or any other pathological marker.